FindTrial
Sign In

Comparison of 2 reveral agents Sugammadex vs Neostigmine for reversal of general anesthhesia

Comparison of Sugammadex vs Neostigmine for reversal of Vecuronium induced Neuromuscular Blockade A Randomised Controlled Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076207
Enrollment
120
Registered
2024-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Reversal of general anesthesia: Comparison of Sugammadex vs Neostigmine for reversal of Vecuronium induced Neuromuscular Blockade,1 hour procedure Control Intervention1: Reversal of gen

Sponsors

Department of anaesthesia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient between 18-65 years of age. Patient belonging to ASA physical status I-•

Exclusion criteria

Exclusion criteria: Anticipation of a difficult airway Known or suspected neuromuscular disorders, Significant renal dysfunction Known or suspected family history of malignant hyperthermia Allergies to narcotics, muscle relaxants

Design outcomes

Primary

MeasureTime frame
Sugammadex provides significantly Faster Reversal Of Vecuronium Induced Neuromuscular BlockadeTimepoint: 1 minutes—

Secondary

MeasureTime frame
1.Sugammadex Provides better recovery of respiratory function following reversal of neuromuscular blockade of general anesthesia 2.Sugammadex as lower incidence of post op nausea and vomiting. Timepoint: 20 minutes—

Countries

India

Contacts

Public ContactDr Yogita Sunil Nepire

1st year post graduate student

yogitanepire@gmail.com9591668859

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026